Zoom Q2 FY2027 revenue rises 4.9% as company cites faster enterprise growth driven by AI-focused execution
Reuters2026/08/26 08:57- Zoom posted Q2 FY2027 revenue of USD 1.28 billion, up 4.9%, led by 7.8% Enterprise growth to 62% of total revenue.
- Management tied Enterprise acceleration to AI-focused execution across Workplace, customer experience, and new AI products; AI-feature users rose 125%.
- Customer experience momentum continued, with CX ARR up at a high double-digit rate; paid AI appeared in nine of the top 10 CX deals.
- Profitability stayed high, with non-GAAP operating income of USD 510 million and a 40% operating margin; non-GAAP EPS was USD 1.55.
- Outlook was raised to revenue of USD 5.09 billion and non-GAAP EPS of USD 6.1; stronger Enterprise trends offset flat Online growth.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage
Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.
2-Yr Benchmark Govt Yields - Germany vs Other Nations
2-Yr Benchmark Govt Yields - U.S. vs Other Nations
10-Yr Benchmark Govt Yields - U.S. vs Other Nations
Crypto prices
More
